EMS-CHEMIE HOLDING Valuation

Q: What is the Fair Price of EMSN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

EMSN (CHF717) is trading above our estimate of [[fair value]] (CHF621.2)

Is EMSN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of EMSN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: EMSN (CHF717) is trading above our estimate of fair value (CHF621.2)

Significantly Below Fair Value: EMSN is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EMSN?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for EMSN. This is calculated by dividing EMSN's market cap by their current preferred multiple.
What is EMSN's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	CHF 16.77b

EMSN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	7.4x
Enterprise Value/EBITDA	30.3x
PEG Ratio	4.7x

Price to Earnings Ratio vs Peers

How does EMSN's PE Ratio compare to its peers?

The above table shows the PE ratio for EMSN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	33x
GIVN Givaudan	37.5x	5.3%	CHF 38.7b
SIKA Sika	32.5x	11.6%	CHF 39.9b
CLN Clariant	35.5x	30.5%	CHF 4.2b
GURN Gurit Holding	26.7x	33.7%	CHF 198.7m
EMSN EMS-CHEMIE HOLDING	36.6x	7.9%	CHF 16.8b

Price-To-Earnings vs Peers: EMSN is expensive based on its Price-To-Earnings Ratio (36.6x) compared to the peer average (33x).

Price to Earnings Ratio vs Industry

How does EMSN's PE Ratio compare vs other companies in the European Chemicals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	9.4%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	9.4%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: EMSN is expensive based on its Price-To-Earnings Ratio (36.6x) compared to the European Chemicals industry average (17.8x).

Price to Earnings Ratio vs Fair Ratio

What is EMSN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EMSN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	36.6x
Fair PE Ratio	25.7x

Price-To-Earnings vs Fair Ratio: EMSN is expensive based on its Price-To-Earnings Ratio (36.6x) compared to the estimated Fair Price-To-Earnings Ratio (25.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst EMSN forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CHF 717.00	CHF 730.63 +1.9%	11.4%	CHF 900.00	CHF 633.00	n/a	8
Jul ’25	CHF 739.50	CHF 675.00 -8.7%	10.5%	CHF 800.00	CHF 580.00	n/a	7
Jun ’25	CHF 744.00	CHF 667.14 -10.3%	9.6%	CHF 800.00	CHF 580.00	n/a	7
May ’25	CHF 737.00	CHF 664.29 -9.9%	9.8%	CHF 800.00	CHF 580.00	n/a	7
Apr ’25	CHF 692.00	CHF 664.29 -4.0%	9.8%	CHF 800.00	CHF 580.00	n/a	7
Mar ’25	CHF 624.00	CHF 655.71 +5.1%	12.2%	CHF 800.00	CHF 547.00	n/a	7
Feb ’25	CHF 658.00	CHF 657.14 -0.1%	12.5%	CHF 800.00	CHF 547.00	n/a	7
Jan ’25	CHF 681.00	CHF 657.14 -3.5%	12.5%	CHF 800.00	CHF 547.00	n/a	7
Dec ’24	CHF 621.50	CHF 657.14 +5.7%	12.5%	CHF 800.00	CHF 547.00	n/a	7
Nov ’24	CHF 621.50	CHF 704.57 +13.4%	11.4%	CHF 850.00	CHF 613.00	n/a	7
Oct ’24	CHF 623.00	CHF 704.57 +13.1%	11.4%	CHF 850.00	CHF 613.00	n/a	7
Sep ’24	CHF 665.50	CHF 700.29 +5.2%	11.6%	CHF 850.00	CHF 613.00	n/a	7
Aug ’24	CHF 726.00	CHF 700.71 -3.5%	11.5%	CHF 850.00	CHF 613.00	CHF 733.50	7
Jul ’24	CHF 677.00	CHF 712.86 +5.3%	14.3%	CHF 900.00	CHF 560.00	CHF 739.50	7
Jun ’24	CHF 704.50	CHF 716.43 +1.7%	14.5%	CHF 900.00	CHF 575.00	CHF 744.00	7
May ’24	CHF 731.50	CHF 720.71 -1.5%	14.5%	CHF 900.00	CHF 575.00	CHF 737.00	7
Apr ’24	CHF 754.00	CHF 722.57 -4.2%	14.4%	CHF 900.00	CHF 575.00	CHF 692.00	7
Mar ’24	CHF 717.00	CHF 702.50 -2.0%	15.1%	CHF 900.00	CHF 575.00	CHF 624.00	6
Feb ’24	CHF 683.00	CHF 684.17 +0.2%	16.6%	CHF 900.00	CHF 575.00	CHF 658.00	6
Jan ’24	CHF 626.00	CHF 684.17 +9.3%	16.6%	CHF 900.00	CHF 575.00	CHF 681.00	6
Dec ’23	CHF 666.50	CHF 700.83 +5.2%	17.8%	CHF 900.00	CHF 575.00	CHF 621.50	6
Nov ’23	CHF 617.50	CHF 756.57 +22.5%	19.4%	CHF 1,001.00	CHF 575.00	CHF 621.50	7
Oct ’23	CHF 628.50	CHF 902.29 +43.6%	10.7%	CHF 1,001.00	CHF 740.00	CHF 623.00	7
Sep ’23	CHF 669.00	CHF 925.14 +38.3%	9.8%	CHF 1,001.00	CHF 740.00	CHF 665.50	7
Aug ’23	CHF 752.00	CHF 925.14 +23.0%	9.8%	CHF 1,001.00	CHF 740.00	CHF 726.00	7

Analyst Forecast: Target price is less than 20% higher than the current share price.